SATIVEX
Dead / Abandoned — Abandoned — after ex parte appeal (as of 23 Jan 2023)
What this means for you
This application is over — abandoned 23 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79266020
- Mark type
- Stylized text
- Filed
- 17 Jul 2019
- Abandoned
- 23 Jan 2023
- Attorney of record
- MICHAEL T OLSEN
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations, namely, for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pharmaceutical preparations for the treatment of neurological conditions and diseases; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions, each of the foregoing for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pure extracts of medicinal plants and herbs for pharmaceutical use; foodstuffs for medicinal purposes; herb teas for medicinal purposes; pharmaceutical preparations for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders; plant extracts for pharmaceutical purposes
Owner
Prosecution history
- 05 Mar 2026 — CHANGE OF OWNER RECEIVED FROM IB
- 11 Dec 2025 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 31 May 2024 — CHANGE OF OWNER RECEIVED FROM IB
- 11 Mar 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 12 Feb 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 10 Feb 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 10 Feb 2023 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 10 Feb 2023 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 23 Jan 2023 — ABANDONMENT - AFTER EX PARTE APPEAL
- 23 Jan 2023 — EXPARTE APPEAL TERMINATED
- 05 Jan 2023 — INTERNATIONAL REGISTRATION RENEWED
- 09 Dec 2022 — EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
- 17 Aug 2022 — NOTIFICATION OF SUBSEQUENT FINAL EMAILED
- 17 Aug 2022 — SUBSEQUENT FINAL EMAILED
- 17 Aug 2022 — SUBSEQUENT FINAL REFUSAL WRITTEN